C. difficile Infection in Colorectal Cancer: Risk Determinants, Outcomes, and Evolving Management Approaches [0.03%]
难辨梭菌在结直肠癌患者中的感染危险因素、结局及管理措施的演变趋势
Mustafa Khalid AbdulJabbar,Susan Saab Manfi Al-Rawi,Bilal Khaleel Midhin et al.
Mustafa Khalid AbdulJabbar et al.
Background: Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and poses a considerable public health challenge; concurrently, Clostridioides difficile infection (CDI) represents a significant hospi...
Primary Malignant Melanoma of the Oesophagus Treated With Immunotherapy: A Case Report and Scoping Review of the Literature [0.03%]
免疫治疗的一例原发性食管恶性黑色素瘤的病例报告和文献综述
Eve Hopping,Lauren Kennedy,Antonio Barbaro et al.
Eve Hopping et al.
Purpose: Primary malignant melanoma of the oesophagus is extremely rare. Given this, there is a paucity of evidence to guide treatment decisions. Traditionally, treatment has included standard modalities of surgery, chemo...
Do Incretin-Based Therapies Influence the Risk of Cholangiocarcinoma in Type 2 Diabetes Patients? Insights from a Systematic Review and Meta-Analysis [0.03%]
基于肠泌素的疗法会增加2型糖尿病患者的胆管癌风险吗？系统评价和Meta分析的新启示
Eric Ricardo Yonatan,Louis Fabio Jonathan Jusni,Steven Alvianto et al.
Eric Ricardo Yonatan et al.
Introduction: Incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase-4 inhibitors (DPP-4Is), are widely used in the management of type 2 diabetes mellitus (T2DM)....
The Prognostic Significance of Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte in Colorectal Cancer: a Meta-Analysis [0.03%]
血小板淋巴细胞比值和单核细胞淋巴细胞比值对结直肠癌预后的预测价值： meta 分析
Xin Meng,Cong Wang,Xin Xu et al.
Xin Meng et al.
Background: This comprehensive review sought to investigate the correlation between PLR and LMR with overall longevity (OS), recurrence-free interval (DFS), and malignancy-related survival (CSS) among individuals diagnose...
Serum GFAP as a Potential Biomarker for Chemotherapy-Associated Cognitive Impairment in Elderly Patients with Gastrointestinal Cancers: An Exploratory Study [0.03%]
老年胃肠肿瘤患者化疗相关性认知功能损伤的血清GFAP潜在生物标志物价值探索性研究
Ozgur Tanriverdi,Ummuhani Ozel-Turkcu
Ozgur Tanriverdi
Introduction: Chemotherapy-associated cognitive impairment (CACI) is a common yet underdiagnosed condition among elderly cancer patients. Glial fibrillary acidic protein (GFAP), a marker of astrocytic activation, has emer...
Observational Study
Journal of gastrointestinal cancer. 2025 Oct 6;56(1):196. DOI:10.1007/s12029-025-01323-8 2025
Prognostic Impact of Cachexia in Patients Undergoing Radical Resection for Colorectal Cancer: A Retrospective Study [0.03%]
恶病质对接受根治性手术治疗结直肠癌患者预后影响的回顾性研究
Hideki Tanda,Masatsune Shibutani,Yuki Seki et al.
Hideki Tanda et al.
Purpose: Tumor progression is influenced by both tumor-intrinsic and host-related factors. Among the latter, cachexia-a multifactorial syndrome involving progressive skeletal muscle loss-has garnered increasing attention ...
Comprehensive Review of Transarterial Chemoembolization Plus Systemic Therapy in Advanced Hepatocellular Carcinoma [0.03%]
经导管动脉化疗栓塞联合系统治疗晚期肝细胞癌综合评价
Arif Akyildiz,Betul Gok Yavuz,Rashad Ismayilov et al.
Arif Akyildiz et al.
Introduction: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the fifth most common cancer worldwide. For patients with unresectable, localized, intermediate-stage HCC, the standard treatment is...
Latent Profile Analysis and Influencing Factors of Fear of Progression in Patients after Endoscopic Submucosal Dissection for Early Gastric Cancer [0.03%]
内镜黏膜下剥离术后早期胃癌患者的进展恐惧的潜在人群分析及影响因素研究
Jianping Zhu,Jianping Song,Hui Ni et al.
Jianping Zhu et al.
Purpose: Fear of progression (FOP) leads to poor clinical outcomes in patients with gastric cancer. This study aimed to clarify the profiles and factors that influence FOP among patients after endoscopic submucosal dissec...
Efficacy and Safety of Dual Therapy with HER2-inhibitors (Pertuzumab and Trastuzumab) in Gastric or Gastroesophageal Tumors: A Systematic Review and Meta-analysis [0.03%]
HER2抑制剂(帕妥珠单抗和曲妥珠单抗)联合治疗胃癌或食管胃结合部腺癌疗效和安全性的系统评价和 meta 分析
Geraldo Lucas Lopes Costa,João Victor Ramos da Cruz,José Roberto Alves et al.
Geraldo Lucas Lopes Costa et al.
Background: The benefit of adding dual HER2 inhibition with Pertuzumab (P) and Trastuzumab (T) to chemotherapy (cT) in HER2-positive gastric or gastroesophageal junction (GEJ) cancer is not yet fully elucidated. ...
Survival Outcomes of Patients with BRAF V600E-Mutant Resectable Extrahepatic Colorectal Oligometastases After Upfront Metastasectomy [0.03%]
upfront切除术后BRAF V600E突变可切除肠外器官限制性转移结直肠癌患者的生存结局
Takashi Mori,Shin Kobayashi,Yuichiro Tsukada et al.
Takashi Mori et al.
Purpose: The negative impact of the BRAF V600E mutation (mBRAF) on survival outcomes has been reported for metastatic colorectal cancer (mCRC), but the role of mBRAF testing in resectable extrahepatic cases remains unclea...